| Profiles RNS

Profile

MD, Zhejiang University

Websites

BU Research
NIH RePORTER Research

Extracellular Hsp70 and Hypothermia in Tumor Therapy
09/01/2012 - 06/30/2018 (Subcontract PI)
Beth Israel Deaconess Medical Center, Inc. NIH NCI
5R01CA119045-10

Extracellular HSP70 and Hyperthermia in Tumor Therapy
09/21/2007 - 07/31/2012 (Subcontract PI)
Beth Israel Deaconess Medical Center, Inc. NIH NCI
5R01CA119045-05

Telomeres in Breast Cancer Cells, A Target and Biomarker for Radiotherapy
01/01/2010 - 12/31/2010 (PI)
Susan G. Komen Breast Cancer Foundation

Combined Telomerase Inhibition and Immunotherapy in the Prevention and Treatment of Mammary Carcinomas
01/15/2006 - 01/14/2010 (PI)
Department of Defense/Army

Development of HSP70-based Vaccine From Fusion Cells for Clinical Use
01/01/2007 - 12/31/2009 (PI)
Ellison Medical Foundation

Role of Telomerase and Telomeres in the Tumorigenesis of Breast Cancer
05/01/2005 - 04/30/2007 (PI)
Susan G. Komen Breast Cancer Foundation

Dendritic/Leukemic Fusion Cell Vaccine Therapy for AML Patients in First Remission: A Phase I Clinical Trial
12/31/2003 - 12/30/2006 (PI)
Leukemia & Lymphoma Society

Antitumor Immunity Induced by Fusion Cells Vaccination
08/01/2000 - 07/31/2005 (PI)
NIH/National Cancer Institute
5 R01 CA87057 04

Fusion of Human Leukemia and Dendritic Cells as a Novel Anti-Leukemia Vaccine
04/16/2002 - 12/30/2004 (PI)
Leukemia & Lymphoma Society

Development of a Novel Vaccine with Fusions of Dendritic and Ovarian Cancer Cells from Patients
04/16/2002 - 07/31/2004 (PI)
Department of Defense/Army

Showing 10 of 11 results. Show All Results

Title

Yr	Title	Project-Sub Proj	Pubs
2003	ANTITUMOR IMMUNITY INDUCED BY FUSION CELLS VACCINATION	5R01CA087057-04	13
2003	ANTITUMOR IMMUNITY INDUCED BY FUSION CELLS VACCINATION	3R01CA087057-03S1	13
2002	ANTITUMOR IMMUNITY INDUCED BY FUSION CELLS VACCINATION	7R01CA087057-03	13
2001	ANTITUMOR IMMUNITY INDUCED BY FUSION CELLS VACCINATION	5R01CA087057-02	13
2000	ANTITUMOR IMMUNITY INDUCED BY FUSION CELLS VACCINATION	1R01CA087057-01	13

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.

iCite Analysis Copy PMIDs To Clipboard

Gong J, Lang BJ, Weng D, Eguchi T, Murshid A, Borges TJ, Doshi S, Song B, Stevenson MA, Calderwood SK. Genotoxic stress induces Sca-1-expressing metastatic mammary cancer cells. Mol Oncol. 2018 08; 12(8):1249-1263.View Related Profiles.

Weng, Desheng
Gong, Jianlin

PMID: 29738110; PMCID: PMC6068352; DOI: 10.1002/1878-0261.12321;

Weng D, Calderwood SK, Gong J. A Novel Heat Shock Protein 70-based Vaccine Prepared from DC-Tumor Fusion Cells. Methods Mol Biol. 2018; 1709:359-369.View Related Profiles.

Weng, Desheng
Gong, Jianlin

PMID: 29177672

Murshid A, Theriault J, Gong J, Calderwood SK. Molecular Chaperone Receptors. Methods Mol Biol. 2018; 1709:331-344. PMID: 29177670; PMCID: PMC6777869; DOI: 10.1007/978-1-4939-7477-1_24;

Lang BJ, Holton KM, Gong J, Calderwood SK. A Workflow Guide to RNA-seq Analysis of Chaperone Function and Beyond. Methods Mol Biol. 2018; 1709:233-252. PMID: 29177664; PMCID: PMC7336811; DOI: 10.1007/978-1-4939-7477-1_18;

Calderwood SK, Gong J, Murshid A. Extracellular HSPs: The Complicated Roles of Extracellular HSPs in Immunity. Front Immunol. 2016; 7:159. PMID: 27199984; PMCID: PMC4842758; DOI: 10.3389/fimmu.2016.00159;

Calderwood SK, Gong J. Heat Shock Proteins Promote Cancer: It's a Protection Racket. Trends Biochem Sci. 2016 Apr; 41(4):311-23. PMID: 26874923; PMCID: PMC4911230; DOI: 10.1016/j.tibs.2016.01.003;

Koido S, Homma S, Kan S, Takakura K, Namiki Y, Kobayashi H, Ito Z, Uchiyama K, Kajihara M, Arihiro S, Arakawa H, Okamoto M, Ohkusa T, Gong J, Tajiri H. Induction of antigen-specific cytotoxic T lymphocytes by fusion cells generated from allogeneic plasmacytoid dendritic and tumor cells. Int J Oncol. 2015 Jun; 46(6):2679. PMID: 25846893; DOI: 10.3892/ijo.2015.2954;

Murshid A, Gong J, Prince T, Borges TJ, Calderwood SK. Scavenger receptor SREC-I mediated entry of TLR4 into lipid microdomains and triggered inflammatory cytokine release in RAW 264.7 cells upon LPS activation. PLoS One. 2015; 10(4):e0122529. PMID: 25836976; PMCID: PMC4383338; DOI: 10.1371/journal.pone.0122529;

Takakura K, Kajihara M, Ito Z, Ohkusa T, Gong J, Koido S. Dendritic-tumor fusion cells in cancer immunotherapy. Discov Med. 2015 Mar; 19(104):169-74. PMID: 25828520

Gong J, Weng D, Eguchi T, Murshid A, Sherman MY, Song B, Calderwood SK. Targeting the hsp70 gene delays mammary tumor initiation and inhibits tumor cell metastasis. Oncogene. 2015 Oct; 34(43):5460-71.View Related Profiles.

Weng, Desheng
Gong, Jianlin
Sherman, Michael

PMID: 25659585; PMCID: PMC7331470; DOI: 10.1038/onc.2015.1;

Showing 10 of 83 results. Show More

Koido S, Gong J. Cell fusion between dendritic cells and whole tumor cells. Methods Mol Biol. 2015; 1313:185-91. PMID: 25947665; DOI: 10.1007/978-1-4939-2703-6_13;

Murshid A, Gong J, Ahmad R, Borges TJ, Calderwood SK. Scavenger receptor SREC-I promotes double stranded RNA-mediated TLR3 activation in human monocytes. Immunobiology. 2015 Jun; 220(6):823-32. PMID: 25641411; PMCID: PMC4424133; DOI: 10.1016/j.imbio.2014.12.011;

Koido S, Homma S, Okamoto M, Takakura K, Gong J, Sugiyama H, Ohkusa T, Tajiri H. Chemoimmunotherapy targeting Wilms' tumor 1 (WT1)-specific cytotoxic T lymphocyte and helper T cell responses for patients with pancreatic cancer. Oncoimmunology. 2014 Nov; 3(10):e958950. PMID: 25941581; PMCID: PMC4292571; DOI: 10.4161/21624011.2014.958950;

Koido S, Kan S, Yoshida K, Yoshizaki S, Takakura K, Namiki Y, Tsukinaga S, Odahara S, Kajihara M, Okamoto M, Ito M, Yusa S, Gong J, Sugiyama H, Ohkusa T, Homma S, Tajiri H. Immunogenic modulation of cholangiocarcinoma cells by chemoimmunotherapy. Anticancer Res. 2014 Nov; 34(11):6353-61. PMID: 25368235

Murshid A, Gong J, Calderwood SK. Hsp90-peptide complexes stimulate antigen presentation through the class II pathway after binding scavenger receptor SREC-I. Immunobiology. 2014 Dec; 219(12):924-31. PMID: 25155057; PMCID: PMC4886339; DOI: 10.1016/j.imbio.2014.08.001;

Koido S, Enomoto Y, Apostolopoulos V, Gong J. Tumor regression by CD4 T-cells primed with dendritic/tumor fusion cell vaccines. Anticancer Res. 2014 Aug; 34(8):3917-24. PMID: 25075013

Koido S, Homma S, Okamoto M, Takakura K, Mori M, Yoshizaki S, Tsukinaga S, Odahara S, Koyama S, Imazu H, Uchiyama K, Kajihara M, Arakawa H, Misawa T, Toyama Y, Yanagisawa S, Ikegami M, Kan S, Hayashi K, Komita H, Kamata Y, Ito M, Ishidao T, Yusa S, Shimodaira S, Gong J, Sugiyama H, Ohkusa T, Tajiri H. Treatment with chemotherapy and dendritic cells pulsed with multiple Wilms' tumor 1 (WT1)-specific MHC class I/II-restricted epitopes for pancreatic cancer. Clin Cancer Res. 2014 Aug 15; 20(16):4228-39. PMID: 25056373; DOI: 10.1158/1078-0432.CCR-14-0314;

Colvin TA, Gabai VL, Gong J, Calderwood SK, Li H, Gummuluru S, Matchuk ON, Smirnova SG, Orlova NV, Zamulaeva IA, Garcia-Marcos M, Li X, Young ZT, Rauch JN, Gestwicki JE, Takayama S, Sherman MY. Hsp70-Bag3 interactions regulate cancer-related signaling networks. Cancer Res. 2014 Sep 1; 74(17):4731-40.View Related Profiles.

Gong, Jianlin
Sherman, Michael
Garcia-Marcos, Mikel
Gummuluru, Suryaram
Colvin, Teresa
Gabai, Vladimir

PMID: 24994713; PMCID: PMC4174322; DOI: 10.1158/0008-5472.CAN-14-0747;

Chou SD, Murshid A, Eguchi T, Gong J, Calderwood SK. HSF1 regulation of ß-catenin in mammary cancer cells through control of HuR/elavL1 expression. Oncogene. 2015 Apr 23; 34(17):2178-88. PMID: 24954509; PMCID: PMC4275421; DOI: 10.1038/onc.2014.177;

Koido S, Homma S, Kan S, Takakura K, Namiki Y, Kobayashi H, Ito Z, Uchiyama K, Kajihara M, Arihiro S, Arakawa H, Okamoto M, Ohkusa T, Gong J, Tajiri H. Induction of antigen-specific cytotoxic T lymphocytes by fusion cells generated from allogeneic plasmacytoid dendritic and tumor cells. Int J Oncol. 2014 Jul; 45(1):470-8. PMID: 24819411; DOI: 10.3892/ijo.2014.2433;

Koido S, Ohkusa T, Homma S, Namiki Y, Takakura K, Saito K, Ito Z, Kobayashi H, Kajihara M, Uchiyama K, Arihiro S, Arakawa H, Okamoto M, Gong J, Tajiri H. Immunotherapy for colorectal cancer. World J Gastroenterol. 2013 Dec 14; 19(46):8531-42. PMID: 24379570; PMCID: PMC3870498; DOI: 10.3748/wjg.v19.i46.8531;

Koido S, Homma S, Okamoto M, Namiki Y, Takakura K, Uchiyama K, Kajihara M, Arihiro S, Imazu H, Arakawa H, Kan S, Komita H, Kamata Y, Ito M, Ohkusa T, Gong J, Tajiri H. Strategies to improve the immunogenicity of anticancer vaccines based on dendritic cell/malignant cell fusions. Oncoimmunology. 2013 Sep 01; 2(9):e25994. PMID: 24228229; PMCID: PMC3820816; DOI: 10.4161/onci.25994;

Koido S, Homma S, Okamoto M, Namiki Y, Kan S, Takakura K, Kajihara M, Uchiyama K, Hara E, Ohkusa T, Gong J, Tajiri H. Improved immunogenicity of fusions between ethanol-treated cancer cells and dendritic cells exposed to dual TLR stimulation. Oncoimmunology. 2013 Aug 01; 2(8):e25375. PMID: 24167764; PMCID: PMC3805650; DOI: 10.4161/onci.25375;

Weng D, Song B, Koido S, Calderwood SK, Gong J. Immunotherapy of radioresistant mammary tumors with early metastasis using molecular chaperone vaccines combined with ionizing radiation. J Immunol. 2013 Jul 15; 191(2):755-63.View Related Profiles.

Weng, Desheng
Gong, Jianlin

PMID: 23772032; PMCID: PMC4085737; DOI: 10.4049/jimmunol.1203286;

Koido S, Homma S, Okamoto M, Namiki Y, Takakura K, Takahara A, Odahara S, Tsukinaga S, Yukawa T, Mitobe J, Matsudaira H, Nagatsuma K, Kajihara M, Uchiyama K, Arihiro S, Imazu H, Arakawa H, Kan S, Hayashi K, Komita H, Kamata Y, Ito M, Hara E, Ohkusa T, Gong J, Tajiri H. Augmentation of antitumor immunity by fusions of ethanol-treated tumor cells and dendritic cells stimulated via dual TLRs through TGF-ß1 blockade and IL-12p70 production. PLoS One. 2013; 8(5):e63498. PMID: 23717436; PMCID: PMC3663747; DOI: 10.1371/journal.pone.0063498;

Calderwood SK, Gong J, Stevenson MA, Murshid A. Cellular and molecular chaperone fusion vaccines: targeting resistant cancer cell populations. Int J Hyperthermia. 2013 Aug; 29(5):376-9. PMID: 23682824; PMCID: PMC4100618; DOI: 10.3109/02656736.2013.792126;

Koido S, Homma S, Okamoto M, Namiki Y, Takakura K, Uchiyama K, Kajihara M, Arihiro S, Imazu H, Arakawa H, Kan S, Komita H, Ito M, Ohkusa T, Gong J, Tajiri H. Fusions between dendritic cells and whole tumor cells as anticancer vaccines. Oncoimmunology. 2013 May 01; 2(5):e24437. PMID: 23762810; PMCID: PMC3667916; DOI: 10.4161/onci.24437;

Koido S, Homma S, Okamoto M, Namiki Y, Takakura K, Uchiyama K, Kajihara M, Ohkusa T, Gong J, Tajiri H. The combination of TLR2 and TLR4 agonists promotes the immunogenicity of dendritic cell/cancer cell fusions. Oncoimmunology. 2013 Jul 01; 2(7):e24660. PMID: 24073361; PMCID: PMC3782132; DOI: 10.4161/onci.24660;

Koido S, Homma S, Okamoto M, Namiki Y, Takakura K, Takahara A, Odahara S, Tsukinaga S, Yukawa T, Mitobe J, Matsudaira H, Nagatsuma K, Uchiyama K, Kajihara M, Arihiro S, Imazu H, Arakawa H, Kan S, Komita H, Ito M, Ohkusa T, Gong J, Tajiri H. Combined TLR2/4-activated dendritic/tumor cell fusions induce augmented cytotoxic T lymphocytes. PLoS One. 2013; 8(3):e59280. PMID: 23555011; PMCID: PMC3598755; DOI: 10.1371/journal.pone.0059280;

Koido S, Gong J. Characterization of structure and direct antigen presentation by dendritic/tumor-fused cells as cancer vaccines. Anticancer Res. 2013 Feb; 33(2):347-54. PMID: 23393323

Murshid A, Gong J, Calderwood SK. Purification, preparation, and use of chaperone-peptide complexes for tumor immunotherapy. Methods Mol Biol. 2013; 960:209-17. PMID: 23329490; PMCID: PMC4100612; DOI: 10.1007/978-1-62703-218-6_17;

Ghosh SK, Uchida M, Yoo B, Ross AW, Gendler SJ, Gong J, Moore A, Medarova Z. Targeted imaging of breast tumor progression and therapeutic response in a human uMUC-1 expressing transgenic mouse model. Int J Cancer. 2013 Apr 15; 132(8):1860-7. PMID: 23015160; PMCID: PMC3573250; DOI: 10.1002/ijc.27872;

Chou SD, Prince T, Gong J, Calderwood SK. mTOR is essential for the proteotoxic stress response, HSF1 activation and heat shock protein synthesis. PLoS One. 2012; 7(6):e39679. PMID: 22768106; PMCID: PMC3387249; DOI: 10.1371/journal.pone.0039679;

Calderwood SK, Murshid A, Gong J. Heat shock proteins: conditional mediators of inflammation in tumor immunity. Front Immunol. 2012; 3:75. PMID: 22566956; PMCID: PMC3342006; DOI: 10.3389/fimmu.2012.00075;

Calderwood SK, Gong J. Molecular chaperones in mammary cancer growth and breast tumor therapy. J Cell Biochem. 2012 Apr; 113(4):1096-103. PMID: 22105880; PMCID: PMC3309170; DOI: 10.1002/jcb.23461;

Murshid A, Gong J, Calderwood SK. The role of heat shock proteins in antigen cross presentation. Front Immunol. 2012; 3:63. PMID: 22566944; PMCID: PMC3342350; DOI: 10.3389/fimmu.2012.00063;

Weng D, Penzner JH, Song B, Koido S, Calderwood SK, Gong J. Metastasis is an early event in mouse mammary carcinomas and is associated with cells bearing stem cell markers. Breast Cancer Res. 2012; 14(1):R18.View Related Profiles.

Weng, Desheng
Gong, Jianlin

PMID: 22277639; PMCID: PMC3496135; DOI: 10.1186/bcr3102;

Koido S, Homma S, Takahara A, Namiki Y, Komita H, Uchiyama K, Ito M, Gong J, Ohkusa T, Tajiri H. Immunotherapy synergizes with chemotherapy targeting pancreatic cancer. Immunotherapy. 2012 Jan; 4(1):5-7. PMID: 22149993; DOI: 10.2217/imt.11.150;

Murshid A, Gong J, Stevenson MA, Calderwood SK. Heat shock proteins and cancer vaccines: developments in the past decade and chaperoning in the decade to come. Expert Rev Vaccines. 2011 Nov; 10(11):1553-68. PMID: 22043955; PMCID: PMC3243109; DOI: 10.1586/erv.11.124;

Koido S, Homma S, Takahara A, Namiki Y, Tsukinaga S, Mitobe J, Odahara S, Yukawa T, Matsudaira H, Nagatsuma K, Uchiyama K, Satoh K, Ito M, Komita H, Arakawa H, Ohkusa T, Gong J, Tajiri H. Current immunotherapeutic approaches in pancreatic cancer. Clin Dev Immunol. 2011; 2011:267539. PMID: 21922022; PMCID: PMC3172984; DOI: 10.1155/2011/267539;

Koido S, Homma S, Takahara A, Namiki Y, Komita H, Nagasaki E, Ito M, Nagatsuma K, Uchiyama K, Satoh K, Ohkusa T, Gong J, Tajiri H. Immunologic monitoring of cellular responses by dendritic/tumor cell fusion vaccines. J Biomed Biotechnol. 2011; 2011:910836. PMID: 21541197; PMCID: PMC3085507; DOI: 10.1155/2011/910836;

Weng D, Song B, Durfee J, Sugiyama V, Wu Z, Koido S, Calderwood SK, Gong J. Induction of cytotoxic T lymphocytes against ovarian cancer-initiating cells. Int J Cancer. 2011 Oct 15; 129(8):1990-2001.View Related Profiles.

Weng, Desheng
Gong, Jianlin
Durfee, John
Sugiyama, Valerie

PMID: 21154809; DOI: 10.1002/ijc.25851;

Murshid A, Theriault J, Gong J, Calderwood SK. Investigating receptors for extracellular heat shock proteins. Methods Mol Biol. 2011; 787:289-302. PMID: 21898244; PMCID: PMC3905792; DOI: 10.1007/978-1-61779-295-3_22;

Weng D, Calderwood SK, Gong J. Preparation of a heat-shock protein 70-based vaccine from DC-tumor fusion cells. Methods Mol Biol. 2011; 787:255-65.View Related Profiles.

Weng, Desheng
Gong, Jianlin

PMID: 21898241; PMCID: PMC4088345; DOI: 10.1007/978-1-61779-295-3_19;

Koido S, Homma S, Hara E, Namiki Y, Takahara A, Komita H, Nagasaki E, Ito M, Ohkusa T, Gong J, Tajiri H. Regulation of tumor immunity by tumor/dendritic cell fusions. Clin Dev Immunol. 2010; 2010:516768. PMID: 21048993; PMCID: PMC2964897; DOI: 10.1155/2010/516768;

Weng D, Cunin MC, Song B, Price BD, Eller MS, Gilchrest BA, Calderwood SK, Gong J. Radiosensitization of mammary carcinoma cells by telomere homolog oligonucleotide pretreatment. Breast Cancer Res. 2010; 12(5):R71.View Related Profiles.

Gilchrest, Barbara
Weng, Desheng
Gong, Jianlin

PMID: 20846433; PMCID: PMC3096958; DOI: 10.1186/bcr2639;

Murshid A, Gong J, Calderwood SK. Heat shock protein 90 mediates efficient antigen cross presentation through the scavenger receptor expressed by endothelial cells-I. J Immunol. 2010 Sep 1; 185(5):2903-17. PMID: 20686127; PMCID: PMC4109054; DOI: 10.4049/jimmunol.0903635;

Koido S, Homma S, Hara E, Namiki Y, Ohkusa T, Gong J, Tajiri H. Antigen-specific polyclonal cytotoxic T lymphocytes induced by fusions of dendritic cells and tumor cells. J Biomed Biotechnol. 2010; 2010:752381. PMID: 20379390; PMCID: PMC2850552; DOI: 10.1155/2010/752381;

Koido S, Hara E, Homma S, Namiki Y, Komita H, Takahara A, Nagasaki E, Ito M, Sagawa Y, Mitsunaga M, Uchiyama K, Satoh K, Arihiro S, Ohkusa T, Gong J, Tajiri H. Dendritic/pancreatic carcinoma fusions for clinical use: Comparative functional analysis of healthy- versus patient-derived fusions. Clin Immunol. 2010 Jun; 135(3):384-400. PMID: 20226739; DOI: 10.1016/j.clim.2010.02.003;

Koido S, Hara E, Homma S, Namiki Y, Ohkusa T, Gong J, Tajiri H. Cancer vaccine by fusions of dendritic and cancer cells. Clin Dev Immunol. 2009; 2009:657369. PMID: 20182533; PMCID: PMC2825547; DOI: 10.1155/2009/657369;

Gong J, Zhang Y, Durfee J, Weng D, Liu C, Koido S, Song B, Apostolopoulos V, Calderwood SK. A heat shock protein 70-based vaccine with enhanced immunogenicity for clinical use. J Immunol. 2010 Jan 1; 184(1):488-96.View Related Profiles.

Weng, Desheng
Gong, Jianlin
Durfee, John

PMID: 19949080; PMCID: PMC2911119; DOI: 10.4049/jimmunol.0902255;

Jaskelioff M, Song W, Xia J, Liu C, Kramer J, Koido S, Gendler SJ, Calderwood SK, Gong J. Telomerase deficiency and telomere dysfunction inhibit mammary tumors induced by polyomavirus middle T oncogene. Oncogene. 2009 Dec 3; 28(48):4225-36. PMID: 19734944; DOI: 10.1038/onc.2009.268;

Gong J, Zhu B, Murshid A, Adachi H, Song B, Lee A, Liu C, Calderwood SK. T cell activation by heat shock protein 70 vaccine requires TLR signaling and scavenger receptor expressed by endothelial cells-1. J Immunol. 2009 Sep 1; 183(5):3092-8. PMID: 19641135; PMCID: PMC2754732; DOI: 10.4049/jimmunol.0901235;

Koido S, Hara E, Homma S, Ohkusa T, Gong J, Tajiri H. Cancer immunotherapy by fusions of dendritic cells and tumor cells. Immunotherapy. 2009 Jan; 1(1):49-62. PMID: 20635973; DOI: 10.2217/1750743X.1.1.49;

Koido S, Homma S, Hara E, Mitsunaga M, Namiki Y, Takahara A, Nagasaki E, Komita H, Sagawa Y, Ohkusa T, Fujise K, Gong J, Tajiri H. In vitro generation of cytotoxic and regulatory T cells by fusions of human dendritic cells and hepatocellular carcinoma cells. J Transl Med. 2008; 6:51. PMID: 18793383; PMCID: PMC2567290; DOI: 10.1186/1479-5876-6-51;

Gong J, Koido S, Calderwood SK. Cell fusion: from hybridoma to dendritic cell-based vaccine. Expert Rev Vaccines. 2008 Sep; 7(7):1055-68. PMID: 18767954; DOI: 10.1586/14760584.7.7.1055;

Murshid A, Gong J, Calderwood SK. Heat-shock proteins in cancer vaccines: agents of antigen cross-presentation. Expert Rev Vaccines. 2008 Sep; 7(7):1019-30. PMID: 18767951; DOI: 10.1586/14760584.7.7.1019;

Apostolopoulos V, Weiner DB, Gong J. Cancer vaccines: methods for inducing immunity. Expert Rev Vaccines. 2008 Sep; 7(7):861-2. PMID: 18767935; DOI: 10.1586/14760584.7.7.861;

Calderwood SK, Gong J, Theriault JR, Mambula SS, Gray PJ. Cell stress proteins: novel immunotherapeutics. Novartis Found Symp. 2008; 291:115-31; discussion 131-40. PMID: 18575270

Calderwood SK, Theriault J, Gray PJ, Gong J. Cell surface receptors for molecular chaperones. Methods. 2007 Nov; 43(3):199-206. PMID: 17920516

Khaleque MA, Bharti A, Gong J, Gray PJ, Sachdev V, Ciocca DR, Stati A, Fanelli M, Calderwood SK. Heat shock factor 1 represses estrogen-dependent transcription through association with MTA1. Oncogene. 2008 Mar 20; 27(13):1886-93. PMID: 17922035; DOI: 10.1038/sj.onc.1210834;

Koido S, Hara E, Homma S, Mitsunaga M, Takahara A, Nagasaki E, Kawahara H, Watanabe M, Toyama Y, Yanagisawa S, Kobayashi S, Yanaga K, Fujise K, Gong J, Tajiri H. Synergistic induction of antigen-specific CTL by fusions of TLR-stimulated dendritic cells and heat-stressed tumor cells. J Immunol. 2007 Oct 1; 179(7):4874-83. PMID: 17878387

Koido S, Hara E, Homma S, Fujise K, Gong J, Tajiri H. Dendritic/tumor fusion cell-based vaccination against cancer. Arch Immunol Ther Exp (Warsz). 2007 Sep-Oct; 55(5):281-7. PMID: 18219758

Koido S, Tanaka Y, Tajiri H, Gong J. Generation and functional assessment of antigen-specific T cells stimulated by fusions of dendritic cells and allogeneic breast cancer cells. Vaccine. 2007 Mar 30; 25(14):2610-9. PMID: 17239504; PMCID: PMC2073001; DOI: 10.1016/j.vaccine.2006.12.035;

Enomoto Y, Bharti A, Khaleque AA, Song B, Liu C, Apostolopoulos V, Xing PX, Calderwood SK, Gong J. Enhanced immunogenicity of heat shock protein 70 peptide complexes from dendritic cell-tumor fusion cells. J Immunol. 2006 Nov 1; 177(9):5946-55.View Related Profiles.

Bharti, Ajit
Gong, Jianlin

PMID: 17056519

Calderwood SK, Theriault JR, Gong J. How is the immune response affected by hyperthermia and heat shock proteins? Int J Hyperthermia. 2005 Dec; 21(8):713-6. PMID: 16338853

Koido S, Hara E, Torii A, Homma S, Toyama Y, Kawahara H, Ogawa M, Watanabe M, Yanaga K, Fujise K, Gong J, Toda G. Induction of antigen-specific CD4- and CD8-mediated T-cell responses by fusions of autologous dendritic cells and metastatic colorectal cancer cells. Int J Cancer. 2005 Nov 20; 117(4):587-95. PMID: 15945098

Koido S, Hara E, Homma S, Torii A, Toyama Y, Kawahara H, Watanabe M, Yanaga K, Fujise K, Tajiri H, Gong J, Toda G. Dendritic cells fused with allogeneic colorectal cancer cell line present multiple colorectal cancer-specific antigens and induce antitumor immunity against autologous tumor cells. Clin Cancer Res. 2005 Nov 1; 11(21):7891-900. PMID: 16278414

Khaleque MA, Bharti A, Sawyer D, Gong J, Benjamin IJ, Stevenson MA, Calderwood SK. Induction of heat shock proteins by heregulin beta1 leads to protection from apoptosis and anchorage-independent growth. Oncogene. 2005 Sep 29; 24(43):6564-73.View Related Profiles.

Bharti, Ajit
Gong, Jianlin

PMID: 16007186

Calderwood SK, Theriault JR, Gong J. Message in a bottle: role of the 70-kDa heat shock protein family in anti-tumor immunity. Eur J Immunol. 2005 Sep; 35(9):2518-27. PMID: 16144035

Koido S, Nikrui N, Ohana M, Xia J, Tanaka Y, Liu C, Durfee JK, Lerner A, Gong J. Assessment of fusion cells from patient-derived ovarian carcinoma cells and dendritic cells as a vaccine for clinical use. Gynecol Oncol. 2005 Nov; 99(2):462-71.View Related Profiles.

Lerner, Adam
Gong, Jianlin
Durfee, John

PMID: 16137749

Tanaka Y, Koido S, Ohana M, Liu C, Gong J. Induction of impaired antitumor immunity by fusion of MHC class II-deficient dendritic cells with tumor cells. J Immunol. 2005 Feb 1; 174(3):1274-80. PMID: 15661883

Koido S, Ohana M, Liu C, Nikrui N, Durfee J, Lerner A, Gong J. Dendritic cells fused with human cancer cells: morphology, antigen expression, and T cell stimulation. Clin Immunol. 2004 Dec; 113(3):261-9.View Related Profiles.

Lerner, Adam
Gong, Jianlin
Durfee, John

PMID: 15507391

Gong J, Koido S, Kato Y, Tanaka Y, Chen D, Jonas A, Galinsky I, DeAngelo D, Avigan D, Kufe D, Stone R. Induction of anti-leukemic cytotoxic T lymphocytes by fusion of patient-derived dendritic cells with autologous myeloblasts. Leuk Res. 2004 Dec; 28(12):1303-12. PMID: 15475072

Avigan D, Vasir B, Gong J, Borges V, Wu Z, Uhl L, Atkins M, Mier J, McDermott D, Smith T, Giallambardo N, Stone C, Schadt K, Dolgoff J, Tetreault JC, Villarroel M, Kufe D. Fusion cell vaccination of patients with metastatic breast and renal cancer induces immunological and clinical responses. Clin Cancer Res. 2004 Jul 15; 10(14):4699-708. PMID: 15269142

Tanaka Y, Koido S, Xia J, Ohana M, Liu C, Cote GM, Sawyer DB, Calderwood S, Gong J. Development of antigen-specific CD8+ CTL in MHC class I-deficient mice through CD4 to CD8 conversion. J Immunol. 2004 Jun 15; 172(12):7848-58. PMID: 15187169

Wang Y, Theriault JR, He H, Gong J, Calderwood SK. Expression of a dominant negative heat shock factor-1 construct inhibits aneuploidy in prostate carcinoma cells. J Biol Chem. 2004 Jul 30; 279(31):32651-9. PMID: 15152009

Raje N, Hideshima T, Davies FE, Chauhan D, Treon SP, Young G, Tai YT, Avigan D, Gong J, Schlossman RL, Richardson P, Kufe DW, Anderson KC. Tumour cell/dendritic cell fusions as a vaccination strategy for multiple myeloma. Br J Haematol. 2004 May; 125(3):343-52. PMID: 15086415

He H, Soncin F, Grammatikakis N, Li Y, Siganou A, Gong J, Brown SA, Kingston RE, Calderwood SK. Elevated expression of heat shock factor (HSF) 2A stimulates HSF1-induced transcription during stress. J Biol Chem. 2003 Sep 12; 278(37):35465-75. PMID: 12813038

Chen D, Xia J, Tanaka Y, Chen H, Koido S, Wernet O, Mukherjee P, Gendler SJ, Kufe D, Gong J. Immunotherapy of spontaneous mammary carcinoma with fusions of dendritic cells and mucin 1-positive carcinoma cells. Immunology. 2003 Jun; 109(2):300-7. PMID: 12757626; PMCID: PMC1782954

Xia J, Tanaka Y, Koido S, Liu C, Mukherjee P, Gendler SJ, Gong J. Prevention of spontaneous breast carcinoma by prophylactic vaccination with dendritic/tumor fusion cells. J Immunol. 2003 Feb 15; 170(4):1980-6. PMID: 12574367

Gong J, Koido S, Chen D, Tanaka Y, Huang L, Avigan D, Anderson K, Ohno T, Kufe D. Immunization against murine multiple myeloma with fusions of dendritic and plasmacytoma cells is potentiated by interleukin 12. Blood. 2002 Apr 1; 99(7):2512-7. PMID: 11895787

Koido S, Tanaka Y, Chen D, Kufe D, Gong J. The kinetics of in vivo priming of CD4 and CD8 T cells by dendritic/tumor fusion cells in MUC1-transgenic mice. J Immunol. 2002 Mar 1; 168(5):2111-7. PMID: 11859096

This graph shows the total number of publications by year, by first, middle/unknown, or last author.

Available to Mentor as: (Review Mentor Role Definitions):

Advisor

Contact for Mentoring: